Paper2970871
Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.
Pui CH and 9 others. Blood, 1988. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients. Papers, record 2970871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2970871
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Differentiation, T-Lymphocyte | Major topic |
| Biomarkers, Tumor | Major topic |
| Leukemia, Lymphoid | Major topic |
| Lymphoma, Non-Hodgkin | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Adolescent | |
| Adult | |
| Animals | |
| Antibodies, Monoclonal | |
| Antigens, Surface | |
| CD8 Antigens | |
| Child | |
| Child, Preschool | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Prognosis | |
| Risk Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-20180 | NCI NIH HHS | United States | P01CA020180 | PubMed and NIH | NIH RePORTER |
| CA-21765 | NCI NIH HHS | United States | P30CA021765 | PubMed and NIH | NIH RePORTER |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36688998 | Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab. | Cancer Immunol Immunother | 2023 | https://conductscience.org/library/papers/36688998 | PubMed |
| 31440093 | iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31440093 | PubMed |
| 8740979 | Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma. | Urol Res | 1996 | https://conductscience.org/library/papers/8740979 | PubMed |
| 8306503 | High serum levels of soluble CD8 in insulin-dependent diabetes. | Clin Exp Immunol | 1994 | https://conductscience.org/library/papers/8306503 | PubMed |
| 8124911 | Soluble CD4 and CD8 molecules in patients with systemic sclerosis. | Clin Rheumatol | 1993 | https://conductscience.org/library/papers/8124911 | PubMed |
| 2523899 | Decreased production of CD8 (T8) antigen after immunotherapy. | J Clin Immunol | 1989 | https://conductscience.org/library/papers/2523899 | PubMed |
| 2332021 | Serum soluble CD8 antigen level is not elevated in mucocutaneous lymph node syndrome (Kawasaki disease) in spite of an increase in serum soluble interleukin 2 receptors. | Eur J Pediatr | 1990 | https://conductscience.org/library/papers/2332021 | PubMed |
| 1934593 | Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency. | Clin Exp Immunol | 1991 | https://conductscience.org/library/papers/1934593 | PubMed |
| 1903673 | Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer. | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1903673 | PubMed |
| 1878895 | Lymphocyte activation in patients with acute myeloid leukaemia. Evidence for the presence of myeloblast antigen? | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1878895 | PubMed |
| 1833097 | High serum levels of CD8 antigen in primary biliary cirrhosis: a possible cause of suppressor cell dysfunction? | Clin Exp Immunol | 1991 | https://conductscience.org/library/papers/1833097 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2970871
GET https://conductscience.org/api/papers/v1/2970871/authors